These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26484946)
1. When the science fails and the ethics works: 'Fail-safe' ethics in the FEM-PrEP study. Kingori P Anthropol Med; 2015 Dec; 22(3):309-25. PubMed ID: 26484946 [TBL] [Abstract][Full Text] [Related]
2. Saying 'No' to PrEP research in Malawi: what constitutes 'failure' in offshored HIV prevention research? Peterson K; Folayan MO; Chigwedere E; Nthete E Anthropol Med; 2015 Dec; 22(3):278-94. PubMed ID: 26422196 [TBL] [Abstract][Full Text] [Related]
3. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention. Herron PD LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191 [TBL] [Abstract][Full Text] [Related]
4. Cultural conundrums: the ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis. Fiereck K Dev World Bioeth; 2015 Apr; 15(1):27-39. PubMed ID: 24373050 [TBL] [Abstract][Full Text] [Related]
5. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker? Venter F; Allais L; Richter M Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241 [TBL] [Abstract][Full Text] [Related]
6. Ethical public health issues for the use of informal PrEP. Brisson J Glob Public Health; 2018 Oct; 13(10):1382-1387. PubMed ID: 28868979 [TBL] [Abstract][Full Text] [Related]
7. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE. Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I; BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719 [TBL] [Abstract][Full Text] [Related]
8. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439 [TBL] [Abstract][Full Text] [Related]
9. The role of male partners in women's participation in research during pregnancy: a case study from the partners demonstration project. Ngure K; Trinidad SB; Beima-Sofie K; Baeten JM; Mugo NR; Bukusi EA; Heffron R; John-Stewart G; Kelley MC Reprod Health; 2017 Dec; 14(Suppl 3):160. PubMed ID: 29297375 [TBL] [Abstract][Full Text] [Related]
10. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions. Hodges-Mameletzis I; Fonner VA; Dalal S; Mugo N; Msimanga-Radebe B; Baggaley R Drugs; 2019 Aug; 79(12):1263-1276. PubMed ID: 31309457 [TBL] [Abstract][Full Text] [Related]
11. PrEP implementation: moving from trials to policy and practice. Cáceres CF; O'Reilly KR; Mayer KH; Baggaley R J Int AIDS Soc; 2015; 18(4 Suppl 3):20222. PubMed ID: 26198349 [TBL] [Abstract][Full Text] [Related]
12. Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria. Peterson K; Folayan MO Bioethics; 2019 Jan; 33(1):35-42. PubMed ID: 30198594 [TBL] [Abstract][Full Text] [Related]
13. Ethical considerations in developing an evidence base for pre-exposure prophylaxis in pregnant women. Sullivan KA; Lyerly AD Reprod Health; 2017 Dec; 14(Suppl 3):171. PubMed ID: 29297377 [TBL] [Abstract][Full Text] [Related]
14. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field. Lykins WR; Luecke E; Johengen D; van der Straten A; Desai TA Drug Deliv Transl Res; 2017 Dec; 7(6):805-816. PubMed ID: 28612340 [TBL] [Abstract][Full Text] [Related]
15. "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program. Przybyla SM; Cerulli C; Bleasdale J; Wilson K; Hordes M; El-Bassel N; Morse DS Subst Abuse Treat Prev Policy; 2020 Nov; 15(1):89. PubMed ID: 33228721 [TBL] [Abstract][Full Text] [Related]
16. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H; PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256 [TBL] [Abstract][Full Text] [Related]
17. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. Corneli AL; Deese J; Wang M; Taylor D; Ahmed K; Agot K; Lombaard J; Manongi R; Kapiga S; Kashuba A; Van Damme L; J Acquir Immune Defic Syndr; 2014 Jul; 66(3):324-31. PubMed ID: 25157647 [TBL] [Abstract][Full Text] [Related]
18. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care. Kenison TC; Badenhop B; Safo S AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya. Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495 [TBL] [Abstract][Full Text] [Related]
20. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B; Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]